PAR PHARMACEUTICAL COMPANIES, INC.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $926.1M | $1.01B | $1.19B |
| Operating income | — | — | — | −$138.6M | $43.3M | $131.5M |
| Net income | — | −$105.9M | — | −$109.0M | $26.3M | $76.9M |
| Total assets | $3.01B | $2.64B | $2.84B | $1.23B | $783.2M | — |
| Total liabilities | — | — | — | — | — | — |
| Equity | $561.1M | $548.1M | $645.1M | $609.6M | $628.4M | $498.7M |
| EPS (diluted) | — | — | — | $-3.07 | $0.75 | $2.25 |
| Shares out. | 100 | — | 36.6M | 36.0M | 35.6M | 34.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- —
- Net margin
- —
- Return on equity
- —
- Return on assets
- —
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $5610660.00
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 8, 2007
- NT 10-Qmissed a reporting deadline ↗Aug 9, 2007
- NT 10-Qmissed a reporting deadline ↗May 9, 2007
- NT 10-Kmissed a reporting deadline ↗Mar 1, 2007
- NT 10-Q/Amissed a reporting deadline ↗Dec 21, 2006
- NT 10-Qmissed a reporting deadline ↗Nov 9, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Other material eventSep 21, 2015
- Entered a material agreement · New financial obligationFeb 25, 2015
- Results of operations · Regulation FD disclosureFeb 10, 2015
- Other material eventSep 22, 2014
- Entered a material agreement · Completed an acquisition or disposition · New financial obligationFeb 20, 2014
- Director / officer changeFeb 19, 2014
- Results of operations · Regulation FD disclosure · Other material eventJan 29, 2014
- Entered a material agreement · Other material eventJan 21, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KSep 21, 2015
- 10-QAug 6, 2015
- 10-QMay 11, 2015
- 10-KMar 13, 2015
- 8-KFORM 8-KFeb 25, 2015
- 8-KFeb 10, 2015
- 10-QNov 12, 2014
- 8-KSep 22, 2014
- 10-QAug 11, 2014
- 10-QMay 15, 2014
- 10-KMar 18, 2014
- 8-KFORM 8-KFeb 20, 2014
- 8-KFORM 8-KFeb 19, 2014
- 8-KFORM 8-KJan 29, 2014
- 8-KJan 21, 2014